Noah Goodman
Chief Business Officer · 3 filings · Latest: Apr 14, 2026
Kymera Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KYMR | Noah Goodman | Chief Business Officer | Apr 14, 2026 | Sale | $90.00 | 1,347 | $121.2K | 50,195.438 | |
KYMR | Noah Goodman | Chief Business Officer | Apr 10, 2026 | Sale | $87.35 | 2,000 | $174.7K | 51,542.438 | |
KYMR | Noah Goodman | Chief Business Officer | Apr 9, 2026 | Sale | $87.50 | 8,264 | $723.1K | 53,542.438 | |
KYMR | Noah Goodman | Chief Business Officer | Apr 9, 2026 | Option Exercise | $21.05 | 2,500 | $52.6K | 61,806.438 | |
KYMR | Noah Goodman | — | Apr 9, 2026 | Proposed Sale | $87.35 | 11,611 | $1.0M | — |